Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

Marijke B. Coomans; Martin J. B. Taphoorn; Neil K. Aaronson; Brigitta G. Baumert; Martin van den Bent; Andrew Bottomley; Alba A. Brandes; Olivier Chinot; Corneel Coens; Thierry Gorlia; Ulrich Herrlinger; Florence Keime-Guibert; Annika Malmstrom; Francesca Martinelli; Roger Stupp; Andrea Talacchi; Michael Weller; Wolfgang Wick; Jaap C. Reijneveld; Linda Dirven; EORTC Quality Life Grp; EORTC Brain Tumor Group

doi:10.1093/nop/npaa033

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

Marijke B. Coomans^*, Martin J. B. Taphoorn, Neil K. Aaronson, Brigitta G. Baumert, Martin van den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstrom, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Linda DirvenEORTC Quality Life Grp, EORTC Brain Tumor Group

^*Corresponding author for this work

GROW - Innovative Cancer Diagnostics & Therapy

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	668-675
Number of pages	8
Journal	Neuro-Oncology Practice
Volume	7
Issue number	6
DOIs	https://doi.org/10.1093/nop/npaa033
Publication status	Published - Dec 2020

Keywords

brain tumor
patient-reported outcome
quality of life
questionnaire
BEVACIZUMAB
VALIDATION

Access to Document

10.1093/nop/npaa033Licence: CC BY-NC

Cite this

Coomans, M. B., Taphoorn, M. J. B., Aaronson, N. K., Baumert, B. G., van den Bent, M., Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmstrom, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., ... EORTC Brain Tumor Group (2020). Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients. Neuro-Oncology Practice, 7(6), 668-675. https://doi.org/10.1093/nop/npaa033

Coomans, Marijke B. ; Taphoorn, Martin J. B. ; Aaronson, Neil K. ; Baumert, Brigitta G. ; van den Bent, Martin ; Bottomley, Andrew ; Brandes, Alba A. ; Chinot, Olivier ; Coens, Corneel ; Gorlia, Thierry ; Herrlinger, Ulrich ; Keime-Guibert, Florence ; Malmstrom, Annika ; Martinelli, Francesca ; Stupp, Roger ; Talacchi, Andrea ; Weller, Michael ; Wick, Wolfgang ; Reijneveld, Jaap C. ; Dirven, Linda ; EORTC Quality Life Grp ; EORTC Brain Tumor Group. / Measuring change in health-related quality of life : the impact of different analytical methods on the interpretation of treatment effects in glioma patients. In: Neuro-Oncology Practice. 2020 ; Vol. 7, No. 6. pp. 668-675.

@article{2dfa6979bcca4d74aea6f756bad5fd80,

title = "Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients",

keywords = "brain tumor, patient-reported outcome, quality of life, questionnaire, BEVACIZUMAB, VALIDATION",

author = "Coomans, {Marijke B.} and Taphoorn, {Martin J. B.} and Aaronson, {Neil K.} and Baumert, {Brigitta G.} and {van den Bent}, Martin and Andrew Bottomley and Brandes, {Alba A.} and Olivier Chinot and Corneel Coens and Thierry Gorlia and Ulrich Herrlinger and Florence Keime-Guibert and Annika Malmstrom and Francesca Martinelli and Roger Stupp and Andrea Talacchi and Michael Weller and Wolfgang Wick and Reijneveld, {Jaap C.} and Linda Dirven and {EORTC Quality Life Grp} and {EORTC Brain Tumor Group}",

year = "2020",

month = dec,

doi = "10.1093/nop/npaa033",

language = "English",

volume = "7",

pages = "668--675",

journal = "Neuro-Oncology Practice",

issn = "2054-2585",

publisher = "Oxford University Press",

number = "6",

}

Coomans, MB, Taphoorn, MJB, Aaronson, NK, Baumert, BG, van den Bent, M, Bottomley, A, Brandes, AA, Chinot, O, Coens, C, Gorlia, T, Herrlinger, U, Keime-Guibert, F, Malmstrom, A, Martinelli, F, Stupp, R, Talacchi, A, Weller, M, Wick, W, Reijneveld, JC, Dirven, L, EORTC Quality Life Grp & EORTC Brain Tumor Group 2020, 'Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients', Neuro-Oncology Practice, vol. 7, no. 6, pp. 668-675. https://doi.org/10.1093/nop/npaa033

Measuring change in health-related quality of life : the impact of different analytical methods on the interpretation of treatment effects in glioma patients. / Coomans, Marijke B.; Taphoorn, Martin J. B.; Aaronson, Neil K.; Baumert, Brigitta G.; van den Bent, Martin; Bottomley, Andrew; Brandes, Alba A.; Chinot, Olivier; Coens, Corneel; Gorlia, Thierry; Herrlinger, Ulrich; Keime-Guibert, Florence; Malmstrom, Annika; Martinelli, Francesca; Stupp, Roger; Talacchi, Andrea; Weller, Michael; Wick, Wolfgang; Reijneveld, Jaap C.; Dirven, Linda; EORTC Quality Life Grp; EORTC Brain Tumor Group.

In: Neuro-Oncology Practice, Vol. 7, No. 6, 12.2020, p. 668-675.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Measuring change in health-related quality of life

T2 - the impact of different analytical methods on the interpretation of treatment effects in glioma patients

AU - Coomans, Marijke B.

AU - Taphoorn, Martin J. B.

AU - Aaronson, Neil K.

AU - Baumert, Brigitta G.

AU - van den Bent, Martin

AU - Bottomley, Andrew

AU - Brandes, Alba A.

AU - Chinot, Olivier

AU - Coens, Corneel

AU - Gorlia, Thierry

AU - Herrlinger, Ulrich

AU - Keime-Guibert, Florence

AU - Malmstrom, Annika

AU - Martinelli, Francesca

AU - Stupp, Roger

AU - Talacchi, Andrea

AU - Weller, Michael

AU - Wick, Wolfgang

AU - Reijneveld, Jaap C.

AU - Dirven, Linda

AU - EORTC Quality Life Grp

AU - EORTC Brain Tumor Group

PY - 2020/12

Y1 - 2020/12

KW - brain tumor

KW - patient-reported outcome

KW - quality of life

KW - questionnaire

KW - BEVACIZUMAB

KW - VALIDATION

U2 - 10.1093/nop/npaa033

DO - 10.1093/nop/npaa033

M3 - Article

C2 - 33304601

VL - 7

SP - 668

EP - 675

JO - Neuro-Oncology Practice

JF - Neuro-Oncology Practice

SN - 2054-2585

IS - 6

ER -